Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial
DiscussionThe BANBOO trial tested the effect of rivaroxaban on the progression of AAA in patients with elevated Hs-CRP for the first time.Trial registrationChiCTR2100051990, ClinicalTrials.gov, registered on 12 October 2021.
Source: Trials - Category: Research Source Type: clinical trials
More News: Abdominal Aortic Aneurysm | Aortic Aneurysm | Aspirin | Cardiology | Cardiovascular | China Health | Clinical Trials | Heart | Heart Attack | Heart Failure | Hospitals | Laboratory Medicine | Research | Stroke | Study | Thrombosis